Nyberg Emma, Konings Sabine C, Lindblom Nils, Israelsson Bodil, Klementieva Oxana, Martinsson Isak, Gouras Gunnar K
Experimental Dementia Research Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden.
Medical Microspectroscopy, Department of Experimental Medical Science, Lund University, Lund, Sweden; CNCR, Center for Neurogenomics & Cognitive Research, Vrije Universiteit Amsterdam, Netherlands.
J Biol Chem. 2025 Jul 15:110479. doi: 10.1016/j.jbc.2025.110479.
Apolipoprotein E4 (ApoE4), the major genetic risk factor for Alzheimer's disease (AD), is vital for understanding cellular processes involved in AD pathogenesis. Evidence implicates endosomes as a central player in AD, where endosomal enlargement in neurons is among the earliest changes in AD. This enlargement was reported to be enhanced in APOE4 carriers. Cells internalize ApoE into endosomes for lipid delivery, and previous studies indicate that ApoE4 influences endosomes. However, the effect of ApoE4 on endosome function seems different depending on cell type, and our understanding of how ApoE4 influences endosomes in mature neurons, the cell type degenerating in AD, remains limited. We aimed to increase understanding of the impact ApoE4 has on endosomal dynamics in primary neurons and whether external triggers, such as time-in-culture/aging, synaptic activity, and cholesterol influence these endosomal changes. We show that without external triggers mature primary neurons from ApoE knockout (KO), ApoE3 and ApoE4 mice show no major differences in endosomal appearance and function and adapt similarly to increased synaptic activity. However, with prolonged time in culture, neurons with ApoE4 show reduced degradative ability, along with decreased number of active lysosomal compartments. Moreover, when supplying aged cultures with cholesterol, ApoE4 neurons have a predisposition to accumulate cholesterol in the endolysosomal system. Taken together, we show that ApoE4 impacts endolysosome function in primary neurons, but that changes emerge only after prolonged time in culture. A better understanding of how ApoE4 impacts neurons could provide important insights into ApoE4 directed therapy for AD.
载脂蛋白E4(ApoE4)是阿尔茨海默病(AD)的主要遗传风险因素,对于理解AD发病机制中涉及的细胞过程至关重要。有证据表明内体在AD中起核心作用,其中神经元内体增大是AD最早出现的变化之一。据报道,APOE4携带者的这种增大更为明显。细胞将ApoE内化到内体中以进行脂质传递,先前的研究表明ApoE4会影响内体。然而,ApoE4对内体功能的影响似乎因细胞类型而异,而我们对ApoE4如何影响成熟神经元(AD中发生退化的细胞类型)内体的了解仍然有限。我们旨在增进对ApoE4对原代神经元内体动力学影响的理解,以及诸如培养时间/衰老、突触活动和胆固醇等外部触发因素是否会影响这些内体变化。我们发现,在没有外部触发因素的情况下,来自载脂蛋白E基因敲除(KO)小鼠、ApoE3和ApoE4小鼠的成熟原代神经元在内体外观和功能上没有重大差异,并且对增加的突触活动有类似的适应性。然而,随着培养时间的延长,携带ApoE4的神经元显示出降解能力下降,同时活性溶酶体区室数量减少。此外,当给老化培养物提供胆固醇时,ApoE4神经元更容易在内溶酶体系统中积累胆固醇。综上所述,我们表明ApoE4会影响原代神经元的内溶酶体功能,但这种变化仅在长时间培养后才会出现。更好地理解ApoE4如何影响神经元可能为AD的ApoE4定向治疗提供重要见解。